Novavax agrees to sell millions of Covid-19 vaccine doses to Europe

Novavax Inc. has signed a deal to sell up to 200 million doses of its Covid vaccine to the European Commission, the company said Wednesday. The deal would cover an initial 100 million doses of NVX-CoV2373, the company's Covid-19 vaccine candidate, with an option for the commission to purchase an additional 100 million doses through 2023, according to a press release. Terms of the deal were not disclosed. Gaithersburg's Novavax (NASDAQ : NVAX) hopes to submit the candidate for review by the European…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news